Expertise in
21
conditions

Dr. Michael C. Hardacre

Radiation Oncology
Renown Regional Medical Center
1155 Mill St, 
Reno, NV 
Accepting New Patients
Expertise in
21
conditions
Renown Regional Medical Center
1155 Mill St, 
Reno, NV 

Overview

Michael Hardacre is a Radiation Oncologist practicing medicine in Reno, Nevada.

Dr. Hardacre is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Breast Cancer, Astrocytoma, Oligodendroglioma, and Gamma Knife Radiosurgery.

He is actively involved in clinical research, participating in 5 clinical trials. Dr. Hardacre is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in IN

Hospital Affiliations

Renown Regional Medical Center
Renown South Meadows Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Renown Regional Medical Center
1155 Mill St, Reno, NV 89502

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 23, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 06, 2026
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2023
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
View 4 Less Clinical Trials
Similar Doctors
Expertise in
20
conditions
Dr. Garrett B. Green
Radiation Oncology
Expertise in
20
conditions
Dr. Garrett B. Green
Radiation Oncology
Referral may be required

Renown Regional Medical Center

1155 Mill St, 
Reno, NV 
 (0.1 miles away)
775-982-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Garrett Green is a Radiation Oncologist practicing medicine in Reno, Nevada. Dr. Green is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, and Atypical Teratoid Rhabdoid Tumor (ATRT). Dr. Green is currently accepting new patients.

Expertise in
22
conditions
Dr. Jaime H. Shuff
Radiation Oncology
Expertise in
22
conditions
Dr. Jaime H. Shuff
Radiation Oncology
Referral may be required

Cancer Care Specialists

5423 Reno Corporate Dr, 
Reno, NV 
 (4.3 miles away)
775-329-0873
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jaime Shuff is a Radiation Oncologist practicing medicine in Reno, Nevada. Dr. Shuff is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Pleuropulmonary Blastoma, and Metastatic Brain Tumor. Dr. Shuff is board certified in American Board Of Radiology. Dr. Shuff is currently accepting new patients.

Expertise in
34
conditions
Dr. Abhinand V. Peddada
Radiation Oncology
Expertise in
34
conditions
Dr. Abhinand V. Peddada
Radiation Oncology
Referral may be required

Daphne Palmer MD Professional Corporation

1155 Mill St # L-11, 
Reno, NV 
 (0.1 miles away)
775-982-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Abhinand Peddada is a Radiation Oncologist practicing medicine in Reno, Nevada. Dr. Peddada is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Gliosarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Peddada is currently accepting new patients.

Frequently Asked Questions about Dr. Michael C. Hardacre

How do I make an appointment with Dr. Michael C. Hardacre?

You can book an appointment with Dr. Michael C. Hardacre by calling their office at 775-982-5638. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Michael C. Hardacre a top-rated expert for Pleuropulmonary Blastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Michael C. Hardacre is classified as an Distinguished expert for Pleuropulmonary Blastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Michael C. Hardacre specialize in?

While Dr. Michael C. Hardacre is a Radiation Oncology, they have specific expertise in Pleuropulmonary Blastoma, Breast Cancer, and Astrocytoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Michael C. Hardacre accept my insurance?

Dr. Michael C. Hardacre accepts most major insurance plans, including Anthem BCBS and Health Care Services Corporation. We recommend calling the office directly at 775-982-5638 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hardacre's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile